DE000A3ENQ51
DE000A3ENQ51
SCHOTT Pharma AG & Co. KGaA I
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 986.210.000 | 957.091.000 | 3.0% |
| Cost of Revenue | 653.746.000 | 634.481.000 | 3.0% |
| Gross Profit | 332.464.000 | 322.610.000 | 3.1% |
| 145.493.000 | 132.654.000 | 9.7% | |
| Operating Income | 186.971.000 | 189.956.000 | 1.6% |
| Pretax Income | 187.756.000 | 183.971.000 | 2.1% |
| Net Income Common Stockholders | 146.454.000 | 149.685.000 | 2.2% |
| -- | -- | -- | |
| -- | -- | -- |